Project Grant HT94252410402
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically exploring...
The Defense Health Agency awarded H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. $842,500 under the Military Medical Research and Development federal grant program (CFDA 12.420) to define the glycoproteome in melanoma progression from June 1, 2023 to May 31, 2026. Through this award, Moffitt Cancer Center will investigate medical solutions for melanoma on the battlefield by defining the glycoproteome, which are glycosylated RNA and proteins, and how their expression changes...
The Project Grant award of $798,673.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The award will fund a 4-year research project from July 2025 to June 2029 to characterize the role of aberrant FGD1 splicing in brain and bone metastasis in clear cell renal cell carcinoma. The H. Lee Moffitt Cancer Center, a National Cancer...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,124,896.00 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, FL. The grant, awarded on July 15, 2025, will support research to characterize the role of aberrant FGD1 splicing in brain and bone metastasis in clear cell renal cell carcinoma over a project period ending on July 14, 2029. As a National...
The U.S. Department of Defense's Defense Health Agency has awarded a $762,168 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a project period from September 30, 2023 to September 29, 2026, is intended to "DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN." As a leading National Cancer...
This $697,590 federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports research at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to evaluate B-T cell cross-talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The grant, with a performance period from July 1, 2024 to June 30, 2027, aims to advance scientific understanding of...
The federal Project Grant award, valued at $968,875.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant funding will support a 3-year research project focused on the "Identification and Assessment of Targets for Immunotherapy in NF2-Associated Schwannomatosis". The research aims to advance the understanding of...
This federal Project Grant award, valued at $168,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida, to cotarget Type 1 PRMTS and YAP1 in order to combat EGFR-mutant lung adenocarcinoma. The grant period runs from September 1, 2024 to August 31, 2025. The Moffitt Cancer Center is a nonprofit,...
The U.S. Defense Health Agency awarded a $1,619,065 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER", supports a 4-year research project to develop and evaluate a behavioral intervention for young adults diagnosed with advanced cancer. As a National...